So sánh phương pháp

	Mô hình hóa Dược lực học (Pharmacophore Modeling)	Cấu trúc liên kết mạng PPI	QSAR
Lĩnh vực	Tin sinh học	Tin sinh học	Tin sinh học
Họ	Process / pipeline	Process / pipeline	Process / pipeline
Năm ra đời	1977	2000	1964
Người khởi xướng	Peter Gund	Peter Uetz	Corwin Hansch
Loại	Pattern-based virtual screening pipeline	Network analysis pipeline	Regression-based predictive modeling pipeline
Công trình gốc	Wermuth, C. G., Ganellin, C. R., Lindberg, P., & Mitscher, L. A. (1998). Glossary of terms used in medicinal chemistry. Pure and Applied Chemistry, 70(5), 1129-1143.	Uetz, P., Giot, L., Cagney, G., Mansfield, T. A., Judson, R. S., Knight, J. R., ... & Lomax, J. (2000). A comprehensive analysis of protein-protein interactions in Saccharomyces cerevisiae. Nature, 403(6770), 623-627.	Hansch, C. & Fujita, T. (1964). Rho-sigma-pi analysis. A method for the correlation of biological activity and chemical structure. Journal of the American Chemical Society, 86(8), 1616-1626.
Tên gọi khác	pharmacophore pattern recognition, 3D pharmacophore	protein interaction networks, interactome analysis, network topology	QSAR model, quantitative structure-activity relationship
Liên quan	3	3	3
Tóm tắt	Pharmacophore modeling identifies the spatial arrangement of molecular features (hydrogen bond donors, acceptors, aromatic rings) that are essential for biological activity. Introduced by Gund in 1977, this ligand-based method creates a three-dimensional pattern that can screen chemical libraries and design new active compounds without requiring receptor structure.	Protein-protein interaction network analysis identifies and characterizes the structural properties of cellular interaction networks. Pioneered by Uetz and colleagues through large-scale yeast two-hybrid screening, this approach reveals topological features like hubs, modules, and motifs that encode functional organization and disease associations.	Quantitative Structure-Activity Relationship (QSAR) modeling predicts biological activity from molecular structure using statistical or machine learning models. Pioneered by Hansch in 1964, QSAR correlates numerical molecular descriptors with measured bioactivity, enabling prediction of activity for untested compounds and rational lead optimization.